Creating a seamless experience for HCPs across all your channels will ensure greater engagement with your brand. Enabling them to find the information they want in a format they prefer should be a key part of your omnichannel strategy.
However, it’s important to remember that the HCP demographic is changing, and with that so should the method of delivering content. According to recent research undertaken by Indegene, 77% of HCPs use digital channels for personal learning and development. So how do we ensure that we serve up content that both engages the HCP and adds value for pharma?
A recent article in PMLiVE highlights the role agencies play in supporting pharma’s omnichannel strategy. Their specialist teams identify the channels and develop the communication plans that pharma can then use to engage with HCPs. Within these plans, it is critical to consider where published scientific content should be leveraged. Digital versions of the articles published in leading medical journals (ePrint) and related content are ‘readily available’ content that can contribute to the effectiveness of the strategy.
We focus on enabling the distribution of scientific copyright content in channels used by Pharma. Using our experience as a Veeva Silver Certified Technology Partner, we work together with the existing pharma communications agency to provide the consistency and technology to enable the provision of ePrint content that they can leverage to enhance your omnichannel approach.
Our platform works within pharma’s existing ecosystem, allowing them to share ePrints, quick-take videos and article research summaries directly with the HCP via their existing channels. Working together with agencies, we can ensure your omnichannel strategy optimises every opportunity to deliver your desired ROI.
To find out more about how Tangent90 can support you to manage your scientific content distribution, please contact us at [email protected].
